Navigation Links
Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
Date:6/9/2009

NEW YORK, June 9 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that on June 5, 2009, it received a letter from the NASDAQ Listing Qualifications Hearings Panel granting the Company an extension through August 31, 2009, to regain compliance with Nasdaq Listing Rule 5550(b), which requires the Company to have a minimum of $2,500,000 in stockholders' equity, or $35,000,000 market value of listed securities, or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years, for continued listing on The Nasdaq Capital Market.

The Company expects to be able to comply with Nasdaq Listing Rule 5550(b) for continued listing on The Nasdaq Capital Market by August 31, 2009; however, there can be no assurance that the Company will be able to do so. Failure to comply with the conditions for listing could result in the delisting of the Company's common stock from The Nasdaq Capital Market.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM)(ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of oth
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
2. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
3. Keryx Biopharmaceuticals Receives Nasdaq Notification
4. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
5. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
8. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
9. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
10. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
11. MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Salt Lake Community College’s Know Greater Heroes program ... winners for 2013. As part of the award, the ... is a leadership training program that involves SLCC athletes who ... eat right, be active, and avoid drugs and alcohol. , ... program each year, and visit more than 30 schools each ...
(Date:5/20/2013)... May 20, 2013 Osborn’s Brain: ... to Anne G. Osborn’s 1993 award winning book Diagnostic ... the all-time bestselling neuroradiology texts. , In this ... touch to make complex topics visually appealing and easy ... brain imaging together with spectacular pathology examples, relevant anatomy, ...
(Date:5/20/2013)... 2013 Nearly 20 percent of kidneys that are ... for transplant due to factors ranging from scarring in ... the organ going too long without blood or oxygen. ... could be "recycled" to help solve the critical shortage ... Medical Center and colleagues, reporting in the journal ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... , Who:    Sloan Gibson, President, USO and ... President of Outreach Initiatives and Partners, ... Street , Representatives from:,              ...          • U.S. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... adult allogeneic stem cell manufacturing, research and development, ... of Medicine and Director of Interventional Cardiology Research ... join the Scientific and Medical Advisory Board for ... of Pennsylvania, Dr. Wilensky divides his time between ...
Breaking Medicine News(10 mins):Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:Osborn’s Brain from Amirsys Publishing Receives Doody’s Top Honors 2Health News:Study suggests new source of kidneys for transplant 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3
... Inc (Seattle WA) has agreed to pay the US ... illegal marketing// of the anti-cancer prescription drug Trisenox, the ... ,According to the government's complaint, CTI promoted the drug ... Food & Drug Administration (FDA). ,The alleged ...
... ladders can result in serious injury and affect people of ... injuries, yet receives little// , if any, instruction on ladder ... in the May issue of the American Journal of Preventive ... Policy (CIRP) at Columbus Children’s Hospital, more than 2.1 million ...
... in 1150AD said about Asthma – , ... in mind is a rational conduct of life//." ... chronic disease which affects almost 300 million worldwide remains the ... most commonly discussed respiratory disease after the common cold. The ...
... a new agent, called "Zorro-LNA," which has the potential ... study, researchers from the Karolinska// Institute in Stockholm, Sweden, ... strands of a gene’s DNA simultaneously, effectively disabling that ... for virtually every human condition caused by or worsened ...
... the rise among kids in the US, according to the largest government ... ,Sugary foods and drinks and nonfluoridated bottled water may be ... ,An estimated 28 percent of U.S. children ages 2 to 5 had ... This compared to a 24 percent rate from 1988 to 1994. ...
... cases of Polio reported globally are 111 out of which 31 ... number of polio cases reported// during the last three years, State ... circulation of wild polio virus following action are being taken: ... 2007 ,? One SNID implemented in UP, Bihar and ...
Cached Medicine News:Health News:CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG 2Health News:Ladder-related Injuries on the Rise in U.S 2Health News:Asthma can Be Checked, Experts are Confident 2Health News:Asthma can Be Checked, Experts are Confident 3Health News:Asthma can Be Checked, Experts are Confident 4Health News:New Agent to Fight Genetic Disorders Found 2Health News:Sugary Foods Turn Kids Teeth Rotten in US 2Health News:Polio Cases In The Country 2
(Date:5/19/2013)...  The non-surgical Stretta® procedure employing ... is effective in control of gastroesophageal reflux disease ... medication 10 years post-procedure, according to an independent, ... Disease Week (DDW) meeting May 18-21, 2013 in ... "The sustained improvement in GERD-HRQL scores and ...
(Date:5/18/2013)... 18, 2013 The Open Paradigm Project, ... Occupy Psychiatry , and leading organizations in ... a social media campaign showcasing video testimonials by ... which focuses on pathology and illness rather than ... American Psychiatric Association,s (APA) rollout of its latest ...
(Date:5/17/2013)... -- The power of plants to cure and rejuvenate, ... depends on the plant kingdom, is the subject of ... Medicine: Healing Plants Around the World, Featuring ... 18 through September 8, 2013. (Photo:  ... attractions include a re-creation of the Western world,s oldest ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2
... Group, Inc. recently published its TreatmentTrends®: Renal Anemia ... based on survey results from ... interviews conducted with ten thought leaders in nephrology.  The ... and focuses specifically on the management of renal anemia ...
... Research Group (MRG), the global authority on medical ... US cardiac resynchronization therapy defibrillator market will be ... chronic resynchronization therapy defibrillators in New York Heart ... The New York Heart Association classification system ranks ...
Cached Medicine Technology:New Report by BioTrends Examines the Treatment of Renal Anemia in China 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
DP 2020 Series 3-chip cameras offer the user unparalleled clarity and definition. Chroma dynamic range is extended and red colour reproduction is superb....
Medicine Products: